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ABSTRACT  
POSTOPERATIVE PAIN AFTER THE USE OF A  
DEXAMETHASONE RINSE AS AN  
IRRIGANT PRIOR TO  
OBTURATION 
 
 
Kenan Tarabishy, D.DS.  
 
Marquette University, 2013 
 
 
Purpose:"The purpose of this randomized, double-blind pilot study was to 
determine the effect of dexamethasone on post-operative pain when used as an intracanal 
rinse prior to obturation.  
 
Materials and Methods:"Nine!adult!volunteers!consented!to!enroll.!They!presented!to!the!Marquette!University!School!of!Dentistry!Endodontic!Department!with!a!diagnosis!of!irreversible!pulpitis.!Patients!recorded!their!baseline!pain!levels!on!the!numering!rating!scale!(NRS).!Patients!were!randomly!assigned!to!either!experimental!or!control!group.!Patients!in!the!experimental!group!received!4!mg/mL!dexamethasone!solution!as!a!final!rinse!prior!to!obturation!were!as!patients!in!the!control!group!received!saline!as!a!final!rinse.!Patients!recorded!their!pain!levels!at!3,!6,!12,!24,!and!48!hours!postNoperatively.!Means!and!standard!deviations!were!calculated.!Treatment!effects!were!analyzed!using!repeated!measures!ANOVA.!Statistical!significance!was!set!at!p<.05.!
 
Results:"Eight!patients!returned the participation forms. Pain reduction after 
endodontic treatment was statistically significant (p=0.039). There was no significant 
difference in post-operative pain between the control and experimental groups (p-0.789).  
 
Conclusion: The patient sample size was not large enough to state any 
conclusions with confidence. However, endodontic treatment remains an effective means 
of reducing post-operative pain. 
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INTRODUCTION 
 
 Pain of odontogenic origin has long been a source of anxiety and fear amongst the 
general population (Sohn & Ismail, 2005). This fear is so great amongst certain 
individuals that it actually serves as a barrier to dental treatment (Nixdorf et al, 2010a; 
Sohn & Ismail, 2005). Odontogenic pain has also been a common source of frustration 
amongst dentists whom have difficulties in completely relieving their patient’s pain 
(Nobuhara et al, 1993). The ability to relieve such terrible pain amongst patients has been 
inconsistent, with many patients continuing to experience discomfort after dental 
treatment is provided (Nixdorf et al, 2010a). No treatment within the dental profession is 
as intimately associated with the fear of pain as is root canal therapy. This perception is 
so prevalent that stating something is “worse than a root canal” is a common way of 
describing terribly painful experiences (Wong & Lytle, 1991). A recent public poll 
sought to emphasize the unpopularity of members of congress by comparing their 
favorability ratings to root canals (Public Policy Polling, 2013). The ability to predictably 
treat pulpal and periapical diseases in a manner that seeks to minimize or even eliminate 
post-operative discomfort experienced by patients could help improve the image of 
dentistry within the public realm (Seltzer & Naidorf, 2004a).  
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LITERATURE REVIEW 
 
Post-operative pain 
 
 
A substantial amount of research has been published investigating the prevalence 
of post-operative discomfort after the initiation, continuation, and completion of 
endodontic therapy. The American Association of Endodontics defines flare-ups as “an 
acute exacerbation of asymptomatic pulp or peridradicular pathosis after the initiation or 
continuation of root canal treatment” (Glossary of Endodontic Terms, 2012).  Tsesis et al 
(2008) evaluated the frequency of flare-ups secondary to endodontic therapy through 
meta-analysis of six studies that included 982 patients. The analysis showed an 8.4% 
frequency of flare-ups (2008). Nixdorf et al (2010a) published a meta-analysis and 
systematic review to estimate the presence of odontogenic pain after at least six months 
following completion of root canal therapy. The analysis included 26 studies and 2,996 
teeth qualified for the final analysis. The frequency of persistent odontogenic pain was 
estimated to be at 5.3% after six months post-treatment (95% CI: 35-7.2%). The authors 
stated that this is likely a more conservative estimate and that the true figure may be 
higher, reflecting the widespread occurrence of post-operative pain. 
One of the challenges facing clinicians is that many patients present with dento-
alveolar pain due to a non-odontogenic source, yet they are treated with conventional 
dental treatments, including root canal therapy. Nixdorf et al (2010b) sought to determine 
the presence of non-odontogenic pain after at least six months following completion of 
root canal therapy. They conducted a meta-analysis of 10 qualifying studies including 
1,125 teeth It was determined that possibly up to half of all cases of persistent tooth pain 
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(3.4%; 95% CI: 1.4-5.5%) may be caused in part by non-odontogenic pain.This 
highlights the importance of proper diagnosis within the dental profession to prevent 
unnecessary irreversible dental treatments such as root canal therapy and eventually in 
many cases, extractions. Improved diagnosis and referral for treatment of pain of non-
odontogenic origin would ultimately help decrease the frequency of reported cases of 
post operative discomfort secondary to endodontic therapy. This in turn could contribute 
to improved public perceptions regarding discomfort associated with endodontic therapy  
(ElMubarak et al, 2010).  
 The presence of post-operative pain can become especially problematic when it is 
caused by neuropathic pain. The International Association for the Study of Pain defines 
neuropathic pain as “pain initiated or caused by a primary lesion in or dysfunction of the 
nervous system” (Merskey & Bogduk, 1994). This type of pain can develop as a result of 
damage to local neural structures during the root canal procedure itself (Nixdorf et al, 
2010a). The damage causes somatosensory changes in the nerves, which manifests as a 
constant, burning, and deep ache at the site of treatment with the absence of any clinical 
signs of pathology. The greatest obstacle that this presents is that this condition is not 
responsive to analgesics, surgery, or any other dental procedures. This painful condition 
causes great distress to the patients and much confusion amongst their dental providers. 
Neuropathic pain has been reported to affect 3% - 12% of patients after endodontic 
therapy (Oshima et al, 2009). The frequency of neuropathic pain after endodontic 
procedures is higher than that of any other dental procedure (Oshima et al, 2009). Oshima 
et al investigated a cohort of sixteen patients and found that neuropathic pain was more 
likely in females (13 of 16), with a predilection for the maxilla (14 of 16). It was found 
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that tricyclic antidepressants were effective in relieving pain in 68.8% of their patients 
(11 of 16). However, 25% (4 of 16) of the patients did not report any relief. In order to 
minimize the risk of neuropathic pain following endodontic treatment, utilization of best 
endodontic treatment practices, including avoiding overinstrumentation and over 
extension of obturation materials is critical (Seltzer & Naidorf, 2004a).  Improved 
practice and techniques may eventually reduce the frequency and development of 
neuropathic pain secondary to endodontic treatment. (Oshima et al, 2009).  
There are numerous, well-documented studies that identify predictors of post-
operative pain. These predictors are significant in educating both practitioners and 
patients. ElMubarak et al (2010) investigated a cohort of 234 patients. They found that 
patients who undergo root canal therapy with a history of pre-operative pain have a 
15.9% incidence of post-operative pain within 24 hours post-treatment, compared to a 
7.1% incidence in those with no reported pre-operative pain. It is important to note that 
numbers of patients evaluated for post-operative pain are too small to attach great value 
pre-operative as a predictive factor. Rather this study demonstrates that endodontic 
treatment is an effective means of relieving pain, with patients having an 89% risk of pain 
free after treatment. The authors found a statistically significant difference in the 
incidence of post-operative pain between vital teeth, 7.8%, and non-vital teeth, 13.7%. In 
a meta-analysis published in 2011, Pak & White confirmed that the incidence of post-
operative pain was greatest in patients who presented with pre-operative pain. Thus it 
appears that in order to affect any meaningful change in the incidence of post-operative 
pain within endodontics that the target population for any pain research be patients with 
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existing pre-operative pain, because they are at greater risk of developing post-operative 
pain (Pak & White, 2011).   
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Pulp Physiology and Inflammation 
 
 The understanding of pulp physiology and the body’s inflammatory processes 
within the context of the human dental pulp is critical to the development of effective 
therapeutic approaches to reducing post-operative pain after root canal treatment (Kim 
1990). The pulp is very unique in the human body in that the physical environment of the 
dental pulp is a low-compliance environment through encasement by dentin (Ingle, 
Bakland, & Baumgartner, 2008). The pulp consists of loose connective tissue that 
contains nerves, blood vessels, lymph vessels, interstitial fluids, and a wide array of 
immune and connective tissue cells. Odontoblasts form the border between the pulp and 
dentin. Fibroblasts are located throughout the pulp that function in maintaining the 
fibrous extra cellular matrix of the pulp (Ingle, Bakland, & Baumgartner, 2008).  
 Blood flow to the pulp is provided by very small arterioles, approximately 100 
µm in diameter that enters through the apical foramen. Blood from the arterioles are 
distributed through an extensive network of branching capillaries, nearly 10 µm in 
diameter, which provides an efficient pathway for the distribution of nutrients. This 
system is so efficient that every minute the pulp is able to replace the entire blood volume 
within the vasculature five to fourteen times. Lymph vessels that are located in the central 
part of the pulp is the only mechanism to remove proteins that leak from the blood 
vessels, and this becomes of critical importance during reversible pulpitis (Oehmke et al 
2003). It is important to note however that there is no source of collateral circulation to 
the pulp, a fact that has significant consequences in the presence of inflammation (Ingle, 
Bakland, & Baumgartner, 2008).  
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 There are both autonomic and sensory nerves present in the dental pulp. 
Sympathetic autonomic nerves have been found to have a regulatory effect on pulpal 
blood flow, with stimulation causing vasoconstriction of the arterioles. There are two 
types of sensory nerve fibers: A-fibers and C-fibers. Nearly 90% of pulpal A-fibers are  
A-delta fibers, which are myelinated, fast conducting, low threshold nerve fibers that are 
unable to survive in hypoxic environments. The remaining 10% of pulpal A-fibers are A-
beta fibers that provide propioceptive feedback. C fibers are unmyelinated, slow 
conducting, and high threshold nerve fibers that are able to survive in hypoxic 
environments. Responses to A-delta fibers are characterized by an immediate and sharp, 
sometimes stabbing-like pain, were as responses to C fibers are characterized by a 
prolonged dull type of pain (Kim 1990).  
 External irritants initiate the inflammatory process in the pulp. These irritants can 
be mechanical irritants such as the friction and heat that is generated when a bur cuts on 
tooth structure. These irritants could also be chemical, which includes bacteria, bacterial 
by-products, and even chemical rinses such as concentrated phosphoric acid utilized 
during cavity preparation. However, the penetration of bacteria and their by-products are 
by far the most common cause of inflammation to the pulp (Siqueira & Barnett, 2004). 
The inflammatory process in the pulp is the same as in the rest of the body, and is 
mediated by the same cells and pathways, with the only difference being the pulp’s low-
compliance environment (Ingle, Bakland, & Baumgartner, 2008).  
Dendritic cells present in the pulp release interleukin-8 (IL-8), which serves as a 
powerful chemotactic agent for other inflammatory cells, including neutrophils, 
macrophages, and mast cells (Siqueira & Barnett, 2004). Histamine, a potent vasodilator, 
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is released from mast cells, resulting in vasoldilation of the arterioles and leakage of the 
venules. This leads to a further increase in inflammatory infiltrate in the pulp as well as 
their chemical mediators. There are two main consequences as a result of this increase in 
infiltrate, both of which are synergistic: Increase in tissue pressure, and increase in 
inflammatory infiltrate (Caviedes-Bucheli et al, 2008). The first is that the increased 
osmotic pressure, a result of the increased protein concentration released from 
inflammatory cells within the pulp, quickly leads to an increase in tissue pressure. The 
low-compliance environment of the pulp prevents the dissipation of the increased tissue 
pressure. As a result, pulpal blood flow is decreased. In high-compliant tissues, increased 
blood flow allows the removal of inflammatory mediators and cells, thus limiting any 
excessive damage to the local site. As a result of the pulp’s decreased blood flow, there is 
instead a rapid accumulation of inflammatory cells and mediators, which only leads to 
greater vascular damage (Heyeraas 1985). This vicious cycle eventually leads to tissue 
necrosis.   
The second main consequence is the cascade of pro-inflammatory mediators and 
their subsequent effects on pulpal tissue throughout the progression of the inflammatory 
process. These mediators are released from multiple cells and include in part: histamine, 
serotonin, prostaglandins, leukotrienes, platelet activating factor (PAF), substance P (SP), 
and a wide host of enzymes that activate several different pro-inflammatory pathways 
(Siqueira & Barnett, 2004). Histamine and serotonin are released from mast cells and 
platelets respectively, yet both act on local vasculature to cause increased permeability 
through the contraction of the blood vessels’ smooth muscle (Seltzer & Naidorf, 2004b). 
Prostaglandins and leukotrienes are very important pro-inflammatory chemical mediators 
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that orginate from the same precursor, arachidonic acid. Cycloxygenase enzymes convert 
arachidonic acid to prostaglandins and thromboxanes and lipoxygenase convert 
arachidonic acid to leukotrienes (Seltzer & Naidorf, 2004b). These pathways are 
diagrammed in figure 2.   
 
 
Figure 1 - Arachidonic acid pathway leading to formation of multiple inflammatory mediators 
(Yudcovitch). !
Prostaglandins function to cause vasodilation in local vessels, promote 
chemotaxis of inflammatory cells, and sensitize the receptors of pain fibers to stimulation 
by other mediators such as bradykinin (Kim 1990). Leukotrienes are from amongst the 
most potent chemotactic agents, attracting neutrophils and macrophages that produce 
extensive tissue and cellular damage through the release of degradative enzymes such as 
lyzozymes (Siqueira & Barnett, 2004). Leukotrienes also have profound effects on 
vascular permeability and increase pain through prolonged stimulation of nerve fibers. 
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Platelet activating factor is released from various immune cells and acts as a chemotactic 
agent, acts on blood vessels to increase vascular permeability, and acting on other cells to 
increase the production of other chemical mediators such as serotonin and leukotrienes 
(Siqueira & Barnett, 2004). SP is a pro-inflammatory neuropeptide that is released by C-
fibers upon stimulation and causes vasodilation, increased vascular permeability, and 
pain by lowering the threshold of sensory nerves (Tuncer et al, 2004). Calcitonin gene 
related peptide, CGRP, is another neuropeptide released by C-fibers upon stimulation that 
acts in a similar fashion as SP (Caviedes-Bucheli et al, 2004). The actions of these 
chemical mediators directly and indirectly cause pain at the site of inflammation. This is 
done directly through lowering the excitability threshold of the A-delta and C-fibers or 
indirectly by way of an increase in edema and tissue pressure. Thus it can be seen that the 
accumulation of pro-inflammatory mediators in the dental pulp quickly leads to a cycle of 
increased vascular permeability, pain, and ultimately tissue necrosis (Kim 1990). This 
cycle is aptly diagrammed in Figure 3.  
 Many recent studies have demonstrated increased levels of inflammatory 
mediators in inflamed pulpal tissues. Bowles et al (2003) measured the concentration of 
SP in normal and inflamed pulps through the insertion of micro-dialysis probes into the 
pulp. The concentrations of SP were eight times higher in teeth  
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Figure 2 - The role of inflammatory mediators in inflammation (Kim 1990). 
 
clinically diagnosed with irreversible pulpitis in comparison to those teeth diagnosed with 
normal pulps. Tuncer et al found elevated levels of SP in inflamed periradicular tissues, 
highlighting the role that it plays in the spread of inflammation from the pulp to the 
periradicular tissues (2004). Lepinski et al (2000) used the same microdialysis probe 
technique as Bowles et al to evaluate pulpal concentrations of bradykinin, a potent pain 
mediator, in teeth with a clinical diagnosis of irreversible pulpitis as compared to normal 
pulps.  Bradykinin concentrations were thirteen times greater in teeth with irreversibile 
pulpitis as compared to normal pulps. Karapanou et al (2008) obtained gingival 
crevicular fluid samples from teeth diagnosed with irreversible pulpitis as well as 
adjacent and contralateral teeth with normal pulpal tissues to evaluate the concentration 
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of IL-8, an important inflammatory chemotactic agent. It was found that interleukin-8 
was significantly elevated in the gingival crevicular fluid of those teeth with irreversibile 
pulpitis. Caviedies-Buchelli et al (2004) found significantly higher levels of CGRP in 
pulpal tissues collected from teeth with irreversible pulpitis as compared to normal teeth. 
A recent article by Yingchun et al (2013) evaluated the expression of EphA7 receptors, a 
tyrosine kinase found on the membranes of inflammatory cells, in teeth with normal 
pulps and teeth with irreversible pulpitis. Higher expressions of the receptors were found 
in inflamed pulps as compared to normal pulps. All of these recent high-level clinical 
studies suggest an active role of inflammatory mediators in pulpal inflammation.  
 Post-operative pain develops when the integrity of the periapical tissues is 
compromised. This can occur during endodontic treatment from mechanical irritants such 
as hand instruments and obturation materials protruding beyond the minor foramen. 
Chemical irritation can occur if any of the solution is extruded beyond the apex. Sealers 
used in obturation are often both mechanical and chemical irritants since many 
commercially available sealers are cytotoxic (Siqueira & Barnett, 2004). In response to 
the tissue irritation, an inflammatory response is initiated, leading to an influx of 
inflammatory cells and mediators as described above, ultimately resulting in post-
operative pain. 
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The Use of Glucocorticosteroids in Dentistry 
 
 
 Disruption of the inflammatory cycle has long been the focus of pain research. 
The primary target sites for pharmacological approaches have been two classes of 
enzymes: phospholipase, which synthesizes arachidonic acid from phospholipids, and 
cyclooxygenase, which synthesizes prostaglandins. Steroidal anti-inflammatory drugs 
(SAID), also known as glucosteroids, are a class of drugs that function by inhibiting 
phospholipase A2, thus reducing the production and concentrations of prostaglandins and 
leukotrienes (Seltzer & Naidorf, 2004b). Non-steroidal anti-inflammatory drugs 
(NSAIDS), are a class of drugs that function by inhibiting cyclooxygenase enzymes, 
which reduces prostaglandins but does not affect leukotriene production (Seltzer & 
Naidorf, 2004b).  
 
Figure 3 - Pharmacologic targets in the arachidonic acid pathway (Yudcovitch). !
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Histology has been used frequently to evaluate the direct anti-inflammatory 
effects of corticosteroids on periapical inflammation and pathology. Metzger et al (2002) 
studied the effect of dexamethasone on the size of periapical lesions in rats. Bone 
resorption is modulated by inflammatory cytokines, thus they hypothesized that 
pharmacological modulation of bone resorption is possible. Periapical lesions were 
induced in molars of rats in two groups, a control group and an experimental group 
administered intramuscular injections of dexamethasone. None of the rats in the 
experimental group developed any abscess or overt sign of infection. Histologic 
evaluation of the periapical lesions of both groups showed that lesions in the 
dexamethasone group were significantly smaller than those of the control group. This 
suggested that the systemic administration of dexamethasone inhibited at least partially, 
the development of inflammatory periapical lesions. It is possible that dexamethasone 
had an inhibitory effect on osteoclasts. The authors found that in the experimental 
dexamethasone group, osteoclasts were more likely to undergo apoptosis, ultimately 
reducing the number of osteoclasts and limiting the potential for greater resorption. 
 Nobuhara et al (1993) also used rats to observe any histologic changes due to the 
application of dexamethasone in inflamed periapical tissues of molars. The distal roots of 
vital and non-vital first molars were over-instrumented with hand files, followed with the 
deposition of either saline or dexamethasone via buccal infiltration. The amounts of 
neutrophils for each specimen were counted at three time points: 6, 24, and 48 hours, and 
at three different locations within the periodontal ligament: adjacent to the apical 
foramen, the middle of the ligament, and adjacent to the cancellous bone. For both vital 
and non-vital cases, the dexamethasone groups demonstrated significantly less neutrophil 
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infiltrate at 48 hours at the apical portion of the periodontal ligament as well as the 
middle of the ligament space. Neutrophils are the hallmark cells of acute inflammation, 
and any potential method to locally decrease neutrophil concentrations may have 
profound impacts on clinical symptoms following endodontic treatment.  
 One of the effects of periapical inflammation is the presence of neural sprouting 
into the periodontal ligament, leading to increased sensitivity upon stimulation of the 
periodontal ligament. Holland (1996) sought to determine if systemic dexamethasone 
affects neural sprouting. Twenty ferrets had root canal treatment completed on 
mandibular canines, with the experimental group administered oral dexamethasone at the 
time of treatment. After three months, the ferrets were killed and specimens were 
prepared for histological evaluation. It was found that innervation density in the apical 
region, as well as the total innervation density of the periodontal ligament, were 
significantly lower in the dexamethasone group as compared to the control group. 
 Isett et al (2003) conducted a double-blind, randomized clinical study to 
investigate the effect of methylprednisolone (depo-medrol) on pulpal concentrations of 
PGE2 and IL-8. Forty patients with diagnoses of irreversible pulpitis participated. After 
being anesthetized, patients were given either intraosseous methylprednisolone or saline. 
The teeth were extracted anywhere from 24 hours to 72 hours after the intraosseous 
injection. The pulp tissues were extracted from the teeth and the concentrations of the 
PGE2 and IL-8 determined via enzyme immunoassay. The pulpal concentrations of PGE2 
were significantly reduced at 24 hours post injection, but not at seventy-two hours. 
Much clinical research also has been produced on the use of SAIDS and their 
effect on inflammation and postoperative pain (Shariar et al, 2013; Marshall & Walton, 
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1984; Liesinger et al, 1993; Jalalzadeh et al, 2010; Chu et al, 2006; Ehrmann et al, 2003; 
Negm et al, 2001). Various modes of administration have been used, ranging from 
intramuscular injections to intra canal medications (Shariar et al, 2013; Marshall & 
Walton, 1984; Liesinger et al, 1993; Jalalzadeh et al, 2010; Chu et al, 2006; Ehrmann et 
al, 2003; Negm et al, 2001). A recent study by Jalalzadeh et al (2010) administered a 
prednisolone pill 30 minutes before treatment to both vital and non-vital teeth in patients 
completed in one visit. 40 patients participated in this double blind study with patients 
divided equally between the placebo group and the prednisolone group. Prednisolone 
resulted in a statistically significant reduction in post-endodontic pain at 6, 12, and 24 
hours following treatment. Marshall and Leisenger (1993) carried out a double blind 
study evaluating the effect of 4 mg dexamethasone i.m. on post-operative pain in patients 
with both vital and non-vital teeth. Fifty patients were included in the placebo controlled 
experiment. Pain levels were recorded at 4 hours, 24 hours, and 48 hours post-
operatively. Patients in the experimental group had significantly lower pain levels at 4 
hours post-operatively compared to the placebo group. Rogers et al (1999) investigated 
the analgesic effects of a dexamethasone rinse in symptomatic vital cases in treatments 
completed in two visits. Forty-eight patients participated and were divided into four 
groups: placebo pills to be taken post-operatively, oral ibuprofen to be taken post-
operatively, dexamethasone (4 mg/ml) intra canal rinse, and ketorolac intra canal rinse. 
The patients recorded their pain levels at 6, 12, 24, and 48 hours post-operatively. 
Dexamethasone provided statistically significant pain relief at 12 hours as compared to 
placebo, but the difference between dexamethasone and ketrolac and ibuprofen was not 
significant statistically.  
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 Ehrmann et al (2003) sought to evaluate whether Ledermix, a corticosteroid and 
antibiotic paste, reduced the incidence of post-operative pain in necrotic teeth. Two 
hundred and twenty one patients were randomized to treatments: ledermix, calcium 
hydroxide (CaOH), and no medication. Patients in the Ledermix group had consistently 
less post-operative pain at all observed time points as compared to patients in the CaOH 
and placebo groups (2003).    
 In 2001, Negm et al (2001) published a double blind, randomized study 
evaluating the efficacy of dexamethasone as an intra-canal medicament in the treatment 
of inter-appointment pain in patients undergoing root canal therapy on vital teeth. Post-
operative pain levels were evaluated up to 48 hours. 480 Patients who needed endodontic 
therapy received either the corticosteroid-antibiotic medicament, or a placebo. Over 93% 
of the patients assigned to the steroid group had complete relief of pain within the first 24 
hours, compared to only 22% in the placebo group. The most significant factor in this 
study was the large size of participants in each group, with over 248 patients in the 
experimental group and 232 patients in the control group. A weakness in the Negm study 
is that the SAID and antibiotic were mixed into one medicament, making it difficult to 
draw conclusions about the efficacy of either component alone. It would have been more 
appropriate to have two experimental groups: a SAID group, and an antibiotic group.  
 The purpose of this prospective, randomized, double blind clinical trial was to 
determine the effect of dexamethasone on post-operative pain in patients with irreversible 
pulpitis when used as an intracanal rinse prior to obturation in treatment completed in one 
visit.   
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MATERIALS & METHODS 
 
 
The research design was based on a study previously executed by Mahajan 
(2012). Second year endodontic residents screened potential participants at the 
Endodontic Clinic at Marquette University School of Dentistry in Milwaukee, Wisconsin. 
The candidate’s medical history was evaluated through their written health history in 
addition to oral examination. A candidate was enrolled if they met the following criteria: 
 Inclusion Criteria: 
• Older than 18 years of age; 
• Being a patient of record; 
• Vital tooth with pulpal diagnosis of symptomatic irreversible pulpitis; 
• A pre-operative pain score of at least a four on the numeric rating scale, 
henceforth known as NRS; 
• Treatment completion in one visit; 
• Potential to achieve canal patency as determined on pre-operative 
radiographs 
• The candidate’s ability to understand and provide informed consent.  
Exclusion Criteria: 
• Did not sign the consent form 
• History of significant medical history, classified as class II or higher by 
the American Society of Anesthesiologists classification; 
• Nursing or pregnant patients; 
• Past history of peptic ulcer or gastrointestinal bleeding; 
• High risk for renal failure or impairment; 
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• Presence of allergy or hypersensitivity to non-steroidal anti-inflammatory 
drugs or corticosteroids; 
• Radiographic evidence of periapical pathology; 
• Recent intake of anti-inflammatory drugs, antibiotics, or narcotics; 
• Presence of adjacent, symptomatic teeth. 
 
The Marquette University Institutional Review Board approved the study 
(Protocol HR-2195, see Appendix), and written informed consent was obtained from 
each patient prior to enrollment in the study. Participants were compensated for their time 
and effort through mail delivery of a $25 VISA® gift card. Pulpal and periapical tests 
were conducted to determine the pulpal and periapical diagnoses. A preoperative 
radiograph was taken to rule out periapical pathology. In addition, a comprehensive 
clinical examination was completed to rule out intra/extraoral swelling, presence of a 
sinus tract, or other major pathology.  
Prior to anesthetizing the treatment area, patients were asked to rate their pain on 
a numeric pain intensity scale otherwise know as a numeric rating scale (NRS) (Figure 
1). The scale was from 0, being no pain, to 10, being the worst possible, unbearable, 
excruciating pain. The NRS score was considered the baseline pain level of the patient. 
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Figure 4 - The numeric rating scale was by patients to determine their pain levels. 
 
Eligible patients were randomly assigned by a research assistant, without 
knowledge of the clinical investigator, to one of two groups: 
• Group 1 was the experimental group that received the dexamethasone rinse in  
addition to standard of care therapy;   
• Group 2 was the control group that received the saline rinse in addition to 
standard of care therapy.   
 Randomization tables were generated with the aid of the (pseudo) random number 
generator in Microsoft® Excel® for Mac 2011 (Microsoft Corp., Redmond (WA)). A 
formula was set to randomly select an integer between 1 and 30 without replacement.  
At the initiation of treatment, patients were anesthetized using 1.7- 5.1 mL of 2% 
lidocaine with 1:100,000 epinephrine (Xylocaine; AstraZeneca LP, DENTSPLY, York 
(PA)) via local infiltration or inferior alveolar nerve block, depending on tooth location. 
Prior to beginning treatment, anesthesia was confirmed by retesting the tooth with Endo-
Ice® (Coltene Whaledent Group, Cuyahoga Falls (OH)). After confirmation of complete 
anesthesia, a rubber dam was placed, the occlusion was adjusted and the tooth was 
accessed. The working length of the root canal instruments was determined and the 
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canal(s) were prepared with hand and rotary instruments. Each canal was prepared to at 
least a size #20 hand file, along with 5.25% sodium hypochlorite (NaOCl) irrigation. A 
modified crown-down technique was employed to enlarge the canal in the coronal, 
middle and apical thirds using RaCe (Brasseler USA, Savannah (GA)) and 
EndoSequence (Brasseler USA, Savannah (GA)) rotary files.  
The modified crown-down technique is a technique in which the coronal third of 
the canal is instrumented first with large tapered rotary files. Afterwards, the apical third 
is instrumented with rotary files, beginning with smaller sized files and increasing in size 
until the master file is reached. Throughout the process, the middle third of the canal is 
instrumented as well.  
After the chemo-mechanical cleaning was completed, a final irrigation with 
5.25% NaOCl, 17% ethylenediaminetetraacetic acid (EDTA), and 2% chlorhexidine 
(CHX) was performed. This was followed by ultrasonic agitation using a size #15 
ultrasonic K-file (Satelec, Merignac, France). Then, the canal was dried with sterile paper 
points. At this point, the research assistant gave the practitioner an unlabled 1 mL 
tuberculin syringe containing a clear solution that was used to rinse the canals. In Group 
1, the solution was 1mL of 4 mg/mL dexamethasone sodium phosphate aqueous solution 
(Luitpold Pharmaceuticals, Shirley (NY)), and in Group 2 the solution was 1mL of 9 
mg/mL sodium chloride in H2O (Luitpold Pharmaceuticals, Shirley (NY)). Patency of the 
canals was rechecked at this point with a hand file of size #10 or greater. The solution 
was then agitated with a size #15 ultrasonic K-file for 30 seconds. The canals were dried 
again with sterile paper points.  
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Obturation was completed by vertical condensation with Brasseler EndoSequence 
.04 ISO sized gutta-percha or .06 ISO sized gutta-percha (Brasseler USA, Savannah 
(GA)) and AH Plus sealer (DeTrey, Dentsply, Ballaigues, Switzerland). A sterile cotton 
pellet was placed in the pulp chamber and the access opening was sealed with Cavit 
temporary filling material (Cavit G; 3M ESPE, Seefeld, Germany).  
After completion of the endodontic treatment, patients were given post-operative 
forms that included rescue medication instructions, explanation of possible adverse 
events, and pain level score collection instructions. As rescue medication, all patients 
received 4 tablets of 600mg ibuprofen each, to be taken only if pain levels reached or 
exceeded 6 on the NRS. In addition, if pain was not manageable, patients were informed 
to contact the principal investigator by phone. Patients were instructed to report also any 
swelling, fever, or persistent infection. For data collection, patients were requested to 
record NRS values at exactly 3, 6, 12, 24, and 48 hrs post-operatively. They were also 
instructed to record the amount of rescue medication and when it was taken. Patients 
were given stamped, self-addressed envelopes to place the form once completed. Patients 
were contacted approximately forty-eight hours post operatively by the principal 
investigator to remind the patients to mail the data collection forms. Upon receipt of the 
envelope, the research assistant recorded the data, and the principal investigator mailed 
the gift card as compensation to the patient’s address. The research data was unblinded to 
the principal investigator at the end of the experiment.
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Statistical Methods 
 
The sample size of necessary root canal treatments was estimated based on the 
following: the study design (two parallel groups, 5 measurement points for each patient), 
a desirable and clinically relevant effect size, type I error rate of 5%, and type II error rate 
of 10%. Figure 4 shows the sample size estimates as a function of various study design (2 
parallel treatment groups, 5 data collection time points) and statistical parameters (type I 
error, type II error, effect size). Given these premises, the goal was to enroll 30 patients.  
 
!
Figure 5 - Sample size as a function of size and power. 
Statistical analyses included computation of means, s.d. and 95% confidence 
intervals. In addition, a repeated measure analysis of variance was executed to investigate 
statistical within- and between-subjects trends and to generate information that could be 
used for the planning of larger clinical studies. The patient was used as a unit for all 
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statistical calculations. The sample included 8 patients (Ntest = 5, Ncontrol = 3). Treatment 
(Test, Control) was the independent variable. Time (baseline, 3 hrs, 6 hrs, 12 hrs, 24 hrs, 
and 48 hrs) was the repeated factor. NRS was the dependent variable. Microsoft® 
Excel® 2010 (Microsoft Corp., Redmond, WA) and SPSS (Version 20, IBM 
Corporation, Chicago, IL) were used for data analyses. 
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RESULTS 
 
 
Nine patients, three males and six females with an average of 36 years of age 
consented to participate in the study. Eight patients completed the pain evaluation forms 
and returned the forms by mail; the ninth patient did not submit her pain evaluation form. 
Of the remaining eight patients, the teeth that were treated included four molars, three 
anteriors, and one premolar. Three patients were assigned to the control group and five to 
the experimental group. Patients in the control group reported an average preoperative 
pain score of 6.7 ± 2.1 (mean ± 1 s.d.). Patients in the experimental group reported an 
average preoperative pain score of 7 ± 1 (mean ± 1 s.d.). The difference in the baseline 
preoperative pain levels between both groups was not statistically significant (p=0.767). 
The table below shows the pain levels of patients of both groups at all observed time 
points.  
Table 1 – Pain levels for patients over a 48-hour period."!!!
Patient Baseline 3hrs 6hrs 12hrs 24hrs 48hrs 
Rescue 
medication 
taken 
Control Group 
Patient 1 9 4 5 7 6 5 0 
Patient 2 5 6 6 6 5 5 3 
Patient 3 6 0 1 0 0 0 0 
Experimental Group 
Patient 4 8 4 4 2 0 0 2 
Patient 5 6 8 4 2 1 1 2 
Patient 6 7 7 9 10 9 10 3 
Patient 7 8 0 0 0 0 0 0 
Patient 8 6 0 0 3 0 0 2 
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 The pain reduction after root canal treatment was statistically significant 
(p=0.039). Patients in the experimental group reported greater average post-operative 
discomfort at three hours and less post operative discomfort at all other time points in 
comparison to the control group. These differences are not statistically significant 
(p=0.789).  
 In the experimental group, two patients experienced moderate to severe 
discomfort at three hours. Of the two patients, one reported moderate pain at six hours, 
and mild to negligible pain at all other time points. The other patient continued to 
experience significant pain, after which she contacted the principal investigator two days 
post treatment complaining of swelling. The patient was seen in the endodontic clinic the 
following day with mild, intraoral swelling localized around the apex of the treated tooth. 
The endodontic resident on emergency rotation that day prescribed the patient a seven-
day course of 150mg clindamycin. The patient experienced mild palpation sensitivity for 
six more weeks until symptoms completely resolved. Three of the five patients 
experienced no post-operative discomfort at 24 hours and 48 hours. This was the only 
patient to report swelling. No other adverse effects were noted. 
 In the control group, two of the three patients reported moderate post-operative 
discomfort at all time points. Only one patient in the control group reported resolution of 
her symptoms by the end of the observed period.  
 Six out of the eight patients reported taking the provided 600mg ibuprofen tablets 
as rescue medication: Four out of the five patients in the experimental group and one out 
of three patients in the control group.  
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Figure 6 - Reported pain levels for individual patients. 
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DISCUSSION!!
 The present study was planned to be a continuation of Mahajan’s thesis work 
(2012) on the use of a dexamethasone rinse as an irrigant prior to obturation. Mahajan 
(2012) found a statistically significant improvement in the post-operative pain 
experienced by patients in the experimental group. Ten patients participated in Mahajan’s 
study. The purpose of the current study was to enact a few procedural modifications 
while expanding the patient base.  
The greatest limitation in the present study was the low number of participants. 
After encouraging results from Mahajan’s (2012) pilot study, one of the primary aims of 
this study was to increase the sample size. However, the study concluded with two less 
participants than the initial study. One possible restrictive requirement may have been the 
requirement that the treatment be completed within one visit. Oftentimes patients who 
presented to the emergency clinic were not able to participate because their insurance 
providers necessitated approval prior to completion of the root canal. Unfortunately there 
is no data available on how many patients were screened and for what reasons they were 
excluded from the study. That data would have been beneficial in designing future 
clinical trials.  
The results of this study indicated that standard of care root canal treatment is an 
effective means to relieve odontogenic pain. The sample size was too small to make any 
conclusion in regards to the efficacy of dexamethasone on post-operative pain. After the 
three-hour mark, the average pain levels of the dexamethasone group were lower than the 
control.  
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Several modifications were made to the original protocol developed by Mahajan 
(2012) to improve the clinical relevance of the study. The study was changed from a 
single blind to a double-blind study through the addition of a placebo rinse. Also, data 
were no longer reported directly to the primary investigator. In an effort to reduce any 
potential bias, patients recorded their pain scores and returned the form via mail, after 
which a research assistant recorded the data. Finally, the pain observation period was 
extended from 24 hours to 48 hours to determine the effects of dexamethasone over a 
longer period of time.   
Previous studies documented the usage of a steroid medication on either inter-
appointment or post-operative discomfort related to endodontic treatments. However, 
most of these studies evaluated post-operative discomfort during multiple appointments. 
Chance et al (1987) and Rogers et al (1999) both evaluated post-operative pain after 
initial treatment. The large clinical trial published by Negm et al (2003) saw treatment 
completed in three visits, with dexamethasone used as an inter-appointment medicament 
rather than a final rinse. Liesinger et al (1993) evaluated post-operative discomfort in 
single visit treatment of vital teeth, however the mechanism of delivery for 
dexamethasone was through intramuscular injection. 
This study focused on single visit treatments due to increasing prevalence 
amongst endodontists of treatment completed in one visit, particularly when treating 
cases with irreversible pulpitis. In a survey by Inamoto et al (2002) completed by 156 
endodontists, 55.8% completed emergency visits in one appointment. Due to risks of 
flare-ups, a lesser percentage of endodontists completed necrotic emergency visits in one 
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apoointment (34.4%). Since the endodontists answered only in response to emergency 
cases, the real number of single appointment treatment is likely much higher. 
Single visit treatments have become more common due to advancements in dental 
materials, namely the development of nickel titanium files rotary files. Unlike traditional 
hand instrumentation, rotary instrumentation removes significant amount of debris away 
from the apex towards the access cavity, reducing the amount of debris that is extruded 
from the apical foramen into the periapical tissues (Cheung et al, 2009). Nickel-titanium 
rotary files as well as improved understanding of irrigation have made single appointment 
treatment much more accessible (Su et al, 2011). Other advantages include greater patient 
acceptance and cost effectiveness (Su et al, 2011).   
Su et al (2011) conducted a systematic review of controlled clinical trials 
comparing outcome of endodontically treated teeth completed in single visits and 
multiple visits. They concluded that the healing rate was similar between the two groups 
and that post-operative pain was significantly lower in the single visit treatment group. 
Kvist et al (2004) carried out a randomized, clinical trial evaluating the antimicrobial 
efficacy of endodontic treatment completed in one visit as compared to two-visit 
treatment in teeth with apical periodontitis. Microbial samples were retrieved from 29% 
of the one visit group and 36% of the two-visit group, with no significant statistical 
difference in the antimicrobial efficacy between the two groups. The Su and Kvist studies 
demonstrate the clinical and anti microbial efficacy of endodontic treatment completed in 
one visit.  
Only teeth with a pulpal diagnosis of irreversible pulpitis were enrolled in the 
present study. Chance et al (1987) investigated the use of an intra-canal corticosteroid in 
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both vital and necrotic teeth and its effects on post-operative pain after initial treatment in 
a randomized, double-blind clinical trial. The frequency of post-operative pain amongst 
vital teeth was greater in the control group as compared to the experimental group. This 
difference was statistically significant, p=0.007 (1987). There was no significant 
difference in post-operative pain in non-vital teeth between the control and experimental 
groups.  
Researchers have utilized many different modes of delivery for corticosteroids. 
Dexamethasone has been administered through local infiltration, extra oral intra-muscular 
injections, intra oral intra-muscular injections, oral dosage, and intra canal rinses (Shariar 
et al, 2013; Marshall & Walton, 1984; Liesinger et al, 1993; Jalalzadeh et al, 2010; Chu 
et al 2006; Ehrmann et al, 2003; Negm et al, 2001). To limit any possible complications 
or side effects that may arise from dexamethasone usage, this study used dexamethasone 
as an intra canal rinse. Dexamethasone has a plasma half-life of 200 minutes and tissue 
half-life of seventy-five hours (Wayman et al, 1994). Systemic absorption of 
dexamethasone may produce unwanted actions at other sites of the body such as a 
decrease in the body’s healing response (Wayman et al, 1994). Wayman et al (1994), 
found that local infiltration of radioactive dexamethasone in the mandibular buccal 
vestibule of rats was rapidly absorbed in the systematic circulation and deposited 
throughout the tissues. Within one hour of injection, radioactive dexamethasone was 
found in the contra-lateral mandible. Although it is difficult to extrapolate conclusions 
from animal studies, the use of an intra-canal dexamethasone rinse may be an effective 
means of limiting systematic absorption of the drug.  
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 This study sought to evaluate post-operative pain up to forty-eight hours post-
treatment. Liesinger et al (1993) showed that the greatest level of post-operative pain 
occurred within the first twenty-four hours following treatment. Their study also showed 
that the greatest therapeutic effects of dexamethasone were observed during this time 
period. By implementing a 48 hour post-treatment observation period it became possible 
to fully document the post-operative pain cycle.  
One patient in the experimental group did develop localized swelling after 
treatment was completed.  No antibiotics were prescribed for patients who enrolled in the 
study unless they developed post-operative complications such as swelling, fever, or 
lymphadenopathy. A Cochrane systematic review by Keenan et al (2006) concluded that 
there was no evidence that antibiotics provided any analgesic effect in patients with 
irreversible pulpitis. Rogers et al (1999) suggested that infections secondary to 
corticosteroid usage may be possible when the inflammatory response is suppressed.  
However, numerous large studies have previously used corticosteroids without any 
evidence of fever, swelling, or malaise (Rogers et al, 1999; Negm et al, 2001; Liesinger 
et al, 1993; Marshall & Walton, 1994; Jalalzadeh et al, 2010).  
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CONCLUSION 
 
 The sample size of this randomized, double blind clinical pilot study does not 
allow any conclusion to be made with confidence on the analgesic efficacy of 
dexamethasone as a final rinse prior to obturation. Standard of care root canal therapy for 
both groups had a statistically significant reduction in post-operative pain, demonstrating 
the effectiveness of root canal therapy. A much larger sample size is needed to determine 
if there any possible effects dexamethasone may have on post-operative pain.  
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